Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1676-1681

  Wallace Jr , Richard J ^a   Meier, Albrecht ^b   Brown, Barbara A ^a   Zhang, Yansheng ^a   Sander, Peter ^b   Onyi, Grace O ^a   Böttger, Erik C ^b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; PEPTIDYLTRANSFERASE; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MYCOBACTERIOSIS; MYCOBACTERIUM CHELONEI; OPERON; POINT MUTATION; PRIORITY JOURNAL; RELAPSE; SPECIES DIFFERENTIATION;

EID: 8944228464     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1676     Document Type: Article

References (41)

1. Bercovier, H., O. Kafri, and S. Sela. 1986. Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genome. Biochem. Biophys. Res. Commun. 136:1136-1141.
2. Berman, S. M., R. C. Kim, D. Haghighat, M. E. Mulligan, J. Fierer, and F. C. Wyle. 1994. Mycobacterium genavense infection presenting as a solitary brain mass in a patient with AIDS: case report and review. Clin. Infect. Dis. 19:1152-1154.
3. Brown, B. A., R. J. Wallace, Jr., and G. Onyi. 1992. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MlC system. Antimicrob. Agents Chemother. 36:1987-1990.
4. Brown, B. A., R. J. Wallace, Jr., and G. Onyi. 1996. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria. Antimicrob. Agents Chemother. 40:874-878.
5. Brown, B. A., R. J. Wallace, Jr., G. Onyi, V. DeRosas, and R. J. Wallace III. 1992. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob. Agents Chemother. 36:180-184.
6. Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, F. R. Sattler, and the AIDS Clinical Trials Group Protocol 157 Study Team. 1994. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. Ann. Intern. Med. 121:905-911.
7. Dautzenberg, B., J. P. Breux, M. Febvre, J. P. Di Mercurio, P. Diot, and J. P. Chauvin. 1992. Clarithromycin containing regimens for mycobacterial infections in 55 non AIDS patients. Abstracts, Annual Meeting of the American Thoracic Society. Am. Rev. Respir. Dis. 145:A809.
8. Dautzenberg, B., F. Papillon, M. Lepitre, C. H. Truffot-Pernod, and J. P. Chauvin. 1993. Mycobacterium xenopi infections treated with clarithromycin containing regimens. abstr. 1125, p. 325. In Program and abstracts of the 33rd Interseience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Dautzenberg, B., D. Piperno, P. Diot, C. Truffot-Pernot, J.-P. Chauvin, and the Clarithromycin Study Group of France. 1995. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Chest 107:1035-1040.
10. Dautzenberg, B., T. Saint Marc, M. C. Meyohas, M. Eliaszewitch, F. Haniez, A. M. Rogues, S. De Wit, L. Cotte, J. P. Chauvin, and J. Grosset. 1993. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch. Intern. Med. 153:368-372.
11. Dautzenberg, B., C. Truffot, S. Legris, M. C. Meyohas, H. C. Berlie, A. Mercat, S. Chevret, and J. Grosset. 1991. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. Am. Rev. Respir. Dis. 144:564-569.
12. Domench, P., M. C. Menandez, and M. J. Garcia. 1994. Restriction fragment length polymorphisms of 16S rRNA gene in the differentiation of fast growing mycobacteria species. FEMS Microbiol. Lett. 116:19-24.
13. Griffith, D. E., R. J. Wallace, Jr., B. A. Brown, W. M. Girard, D. T. Murphy, and G. O. Onyi. 1995. Azithromycin monotherapy for HIV (-) patients with Mycobacterium avium intracellulare complex lung disease. Abstracts of Annual Meeting of the American Thoracic Society. Am. J. Respir. Crit. Care Med. 151:A477.
14. Heifets, L., N. Mor, and J. Vanderkolk. 1993. Mycobacterium avium strains resistant to Clarithromycin and azithromycin. Antimicrob. Agents Chemother. 37:2364-1370.
15. Kauppinen, J., R. Mäntyjärvi, and M.-L. Katila. 1994. Random amplified polymorphic DNA genotyping of Mycobacterium malmoense. J. Clin. Microbiol. 32:1827-1829.
16. Kiehn, T. E., and M. White. 1994. Mycobacterium haemophilum: an emerging pathogen. Eur. J. Clin. Microbiol. Infect. Dis. 13:925-931.
17. Koletar, S. L. 1994. Azithromycin (AZ) improves survival in AIDS patients with disseminated Mycobacterium avium complex (MAC), abstr. I199. p. 211. In Program and abstracts of the 34th Interseience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
19. Maxson, S., G. E. Schutze, and R. F. Jacobs. 1994. Mycobacterium abscessus osteomyelitis: treatment with clarithromycin. Infect. Dis. Clin. Pract. 3:203-205.
20. Mazurek, G. H., S. Hartman, Y. Zhang, B. A. Brown, J. S. R. Hector, D. Murphy, and R. J. Wallace, Jr. 1993. Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J. Clin. Microbiol. 31:390-394.
21. Meier, A., P. Kirschner, S. Burkhardt, V. A. Steingrube, B. A. Brown, R. J. Wallace, Jr., and E. C. Böttger. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384.
22. Meier, A., R. J. Wallace, Jr., B. A. Brown, P. Sander, L. Heifets, and E. C. Bötiger. 1995. Molecular mechanisms of resistance to Clarithromycin in Mycobacterium avium-intracellulare complex, abstr. U-41, p. 124. In Abstracts of the 95th General Meeting of the American Society tor Microbiology. American Society for Microbiology, Washington, D.C.
23. Mushatt, D. M., and R. S. Witzig. 1995. Successful treatment of Mycobacterium abscessus infections with multidrug regimens containing clarithromycin. Clin. Infect. Dis. 20:1411-1412.
24. Nadal, D., R. Caduff, R. Kraft, M. Salfinger, T. Bodmer, P. Kirschner, E. C. Böttger, and U. B. Schaad. 1993. Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 12:37-43.
25. Nash, K. A., and C. B. Inderlied. 1995. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob. Agents Chemother. 39:2625-2630.
26. Pang, Y., B. A. Brown, V. A. Steingrube, R. J. Wallace, Jr., and M. C. Roberts. 1994. Tetracycline resistance determinants in Mycobacterium and Streptomyces species. Antimicrob. Agents Chemother. 38:1408-1412.
27. Pernodet, J.-L., F. Bocrard, M.-T. Alegre, M.-H. Blondelet-Rouvult, and M. Guérineau. 1988. Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens. EMBO J. 7:277-282.
28. Silcox, V. A., R. C. Good, and M. M. Floyd. 1981. Identification of clinically significant Mycobacterium fortuitum complex isolates. J. Clin. Microbiol. 14: 686-691.
29. Steingrube, V. A., R. J. Wallace, Jr., L. C. Steele, and D. R. Nash. 1991. Mercuric reductase activity and evidence of broad-spectrum mercury resistance among clinical isolates of rapidly growing mycobacteria. Antimicrob. Agents Chemother. 35:814-823.
30. Swenson, J. M., R. J. Wallace, Jr., V. A. Silcox, and C. Thornsherry. 1985. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob. Agents Chemother. 28:807-811.
31. Swettler, S. M., S. E. Kindel, and B. R. Smoller. 1993. Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with pre-existing pulmonary colonization. J. Am. Acad. Dermatol. 28:352-355.
32. Tebas, P., F. Sultan, R. J. Wallace, Jr., and V. Fraser. 1995. Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. Clin. Infect. Dis. 20:443-444.
33. Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480.
34. Wallace, R. J., Jr. Unpublished data.
35. Wallace, R. J., Jr., B. A. Brown, D. E. Griffith, W. M. Girard, D. T. Murphy, G. O. Onyi, V. A. Steingrube, and G. H. Mazurek. 1994. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am. J. Respir. Crit. Care Med. 149:1335-1341.
36. Wallace, R. J., Jr., S. I. Hull, D. G. Bobey, K. E. Price, J. M. Swenson, L. Steele, and L. Christensen. 1985. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonae. Am. Rev. Respir. Dis. 132:409-416.
37. Wallace, R. J., Jr., A. Meier, and E. C. Böttger. Unpublished data.
38. Wallace, R. J., Jr., J. M. Swenson, V. A. Silcox, R. C. Good, J. A. Tschen, and M. S. Stone. 1983. Spectrum of disease due to rapidly growing mycobacteria. Rev. Infect. Dis. 5:657-679.
39. Wallace, R. J., Jr., D. Tanner, P. J. Brennan, and B. A. Brown. 1993. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann. Intern. Med. 119:482-486
40. Wallace, R. J., Jr., Y. Zhang, B. A. Brown, V. Fraser, G. H. Mazurek, and S. Maloney. 1993. DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. J. Clin. Microbiol. 31:2697-2701.
41. Young, L. S., L. Wiviott, M. Wu, P. Kolonoski, R. Bolan, and C. B. Inderlied. 1991. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 338:1107-1109.